Navigation Links
Dr. Karen E. Boyle Joins Chesapeake Urology Associates as Director of Reproductive Medicine and Surgery, Sexuality and Aesthetics
Date:12/8/2008

CUA expands service in vasectomy reversal, infertility, sperm retrieval, labiaplasty, vaginal rejuvenation, erectile dysfunction, varicocele repair, genital cosmetic surgery

Multimedia content available at http://www.chesapeakeurology.com/DrKarenBoyle

BALTIMORE, Dec. 8 /PRNewswire/ -- Dr. Sanford J. Siegel, President and CEO of Chesapeake Urology Associates (CUA), announces Dr. Karen E. Boyle as a new partner to the practice. Dr. Boyle, a Board Certified Urologic Surgeon will focus on male fertility, male sexuality (such as erectile dysfunction), female sexuality and genital aesthetic surgery (i.e., laser labiaplasty and laser vaginal rejuvenation).

As Director of the new division, Dr. Boyle creates a new dynamic in male fertility and sexual health. This comprehensive approach treats the entire realm of reproductive and sexual health facing patients. "When people hear 'urology.' they think only about men and only about urinary problems," explains Dr. Boyle. "Many don't understand the depth and breadth our specialty encompasses and specifically how sexual health can be an indicator of broader health issues." Dr. Boyle also serves as Director of Male Fertility for nationally renowned Shady Grove Fertility Reproductive Science Center.

Dr. Boyle specializes in:

Male fertility

  • Infertility evaluation
  • Azoospermia: Zero Sperm Count
  • Microsurgical vasectomy reversal
  • Microsurgical sperm retrieval

Male sexual health

  • Vasectomy
  • Erectile dysfunction
  • Ejaculato
    '/>"/>

SOURCE Chesapeake Urology Associates
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Karen Haney Joins The Turning Point Group as Partner and Vice President of Client Services - Healthcare
2. Speaker-Elect Karen Bass and Assemblymember Mary Hayashi to Promote Quality Dental Care for Children
3. Precyse Solutions Appoints Karen Heisler as New Corporate Vice President, Human Resources
4. A Journal for Karen: Author Shares Gift of Love for Sister with Readers Everywhere Touched by Cancer
5. Phillies Pitcher Jamie Moyer and Wife Karen Continue National Expansion - Bringing Bereavement Camps for Kids to Every Major League Baseball City
6. Physician Assistant Karen Bass Elected Speaker Elect of California State Assembly
7. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
8. Houston Mother Who Nearly Lost Her Daughter to Influenza Joins American Lung Associations Faces of Influenza Campaign to Promote Annual Vaccination
9. Dr. Jonathan White Joins Haemonetics as Head of Research and Development
10. TV Hero Joins Other Heroes from Around the Country to Educate and Celebrate Inspiring Stories from the Community of People with Epilepsy
11. SurgiCount Medical Joins The Leapfrog Group
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Circadiance Launches NEW Zzzephyr Seal 28TM 29 for Its SleepWeaver 28TM 29 ADVANCE Mask Now Available in Three Colors 60056 1Circadiance Launches NEW Zzzephyr Seal 28TM 29 for Its SleepWeaver 28TM 29 ADVANCE Mask Now Available in Three Colors 60056 2STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 1STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 2STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 3STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 4STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 5STAAR Surgical Collamer 28R 29 Accommodating Study Team Reports First Phase Assessments at AAO 60052 6Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 1Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 2Pharmalink AB Receives Patent for Nefecon 28R 29 Principle 5674 3